An investigation into the crystallization tendency/kinetics of amorphous active pharmaceutical ingredients: A case study with dipyridamole and cinnarizine
Authors:
- 1 July 2016
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 104, 59-71
Abstract
No abstract availableKeywords
Funding Information
- Science Foundation Ireland research centres (12/RC/2275)
This publication has 69 references indexed in Scilit:
- Correlation between Glass-Forming Ability and Fragility of Pharmaceutical CompoundsThe Journal of Physical Chemistry B, 2015
- Practical Approach for Measuring Heat Capacity of Pharmaceutical Crystals/Glasses by Modulated-Temperature Differential Scanning CalorimetryChemical and Pharmaceutical Bulletin, 2013
- Dynamics of Ribavirin Glass in the Sub-Tg Temperature RegionThe Journal of Physical Chemistry B, 2011
- An Investigation into the Dissolution Properties of Celecoxib Melt Extrudates: Understanding the Role of Polymer Type and Concentration in Stabilizing Supersaturated Drug ConcentrationsMolecular Pharmaceutics, 2011
- Solubility Advantage of Amorphous Drugs and Pharmaceutical CocrystalsCrystal Growth & Design, 2011
- Current status of amorphous formulation and other special dosage forms as formulations for early clinical phasesJournal of Pharmaceutical Sciences, 2009
- Role of Thermodynamic, Molecular, and Kinetic Factors in Crystallization from the Amorphous StateJournal of Pharmaceutical Sciences, 2008
- Physics of amorphous solidsJournal of Pharmaceutical Sciences, 2004
- Crystalline solidsAdvanced Drug Delivery Reviews, 2001
- The use of MTDSC to assess the amorphous phase content of a micronised drug substanceInternational Journal of Pharmaceutics, 1999